Whitehawk Therapeutics awarded Bryan Ball 183,266 derivative securities through two transactions at $0 per share. The transactions dated 2026-09-15 left him with 91,633 derivative securities, giving investors the stated award size, transaction price and resulting reported holding in one insider transaction record for the company.

Key Highlights

  • The transactions were dated 15 September 2026.
  • The derivative securities were awarded at $0 per share.
  • Bryan Ball’s reported holding after the transactions was 91,633 derivative securities.

Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) awarded Bryan Ball 183,266 derivative securities across two transactions. The transactions listed a per-share award price of $0.

Two Derivative Awards Recorded on 15 September 2026

The transactions were recorded on 15 September 2026 under code A, which identifies an award or grant. The record lists BALL BRYAN with the remark “See remarks.” Following the transactions, his reported ownership was 91,633 derivative securities. The award and resulting holding are separate figures in the transaction record. The first measures the securities covered by the two transactions, while the second identifies the derivative securities reported as owned afterward. Whitehawk Therapeutics’ record therefore sets out the transaction quantity, the per-share award price and the post-transaction holding.